These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30453756)

  • 21. Attitudes of patients with cutaneous melanoma toward prognostic testing using the 31-gene expression profile test.
    Ahmed K; Siegel JJ; Morgan-Linnell SK; LiPira K
    Cancer Med; 2023 Jan; 12(2):2008-2015. PubMed ID: 35915969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.
    Newcomer K; Robbins KJ; Perone J; Hinojosa FL; Chen D; Jones S; Kaufman CK; Weiser R; Fields RC; Tyler DS
    Curr Probl Surg; 2022 Jan; 59(1):101030. PubMed ID: 35033317
    [No Abstract]   [Full Text] [Related]  

  • 23. New prognostic factors and developing therapy of cutaneous melanoma.
    Vihinen PP; Pyrhönen SO; Kähäri VM
    Ann Med; 2003; 35(2):66-78. PubMed ID: 12795336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline determinants of clinical outcome of cutaneous melanoma.
    Vogelsang M; Wilson M; Kirchhoff T
    Pigment Cell Melanoma Res; 2016 Jan; 29(1):15-26. PubMed ID: 26342156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients.
    Berger AC; Davidson RS; Poitras JK; Chabra I; Hope R; Brackeen A; Johnson CE; Maetzold DJ; Middlebrook B; Oelschlager KM; Cook RW; Monzon FA; Miller AR
    Curr Med Res Opin; 2016 Sep; 32(9):1599-604. PubMed ID: 27210115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
    Dhillon S; Duarte-Bateman D; Fowler G; Hagstrom MNE; Lampley N; Olivares S; Fumero-Velázquez MS; Vu K; Wayne JD; Gastman BR; Vetto J; Gerami P
    Arch Dermatol Res; 2023 Oct; 315(8):2295-2302. PubMed ID: 36977840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic potential of alternative transcript isoforms across human tumors.
    Trincado JL; Sebestyén E; Pagés A; Eyras E
    Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular diagnosis of melanocytic tumors].
    Bauer J
    Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?
    Martinez SR; Hoon DS
    J Cell Biochem; 2005 Oct; 96(3):473-83. PubMed ID: 16088931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing Genetic Expression Profiles in Melanoma Diagnosis.
    Leachman SA; Mengden Koon S; Korcheva VB; White KP
    Dermatol Clin; 2017 Oct; 35(4):537-544. PubMed ID: 28886810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor biomarkers in melanoma.
    Ugurel S; Utikal J; Becker JC
    Cancer Control; 2009 Jul; 16(3):219-24. PubMed ID: 19556961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular techniques for predicting behaviour in melanocytic neoplasms.
    Lee CY; Gerami P
    Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Benefit Implication of Gene Expression Profiling and Adjuvant Therapy in Stage IIIA Melanoma.
    Hu Y; Briggs A; Marchetti MA; Ariyan CE; Coit DG; Bartlett EK
    J Am Coll Surg; 2020 Nov; 231(5):547-554.e1. PubMed ID: 32889093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic gene expression profile testing to inform use of adjuvant therapy: A survey of melanoma experts.
    Fastner S; Shen N; Hartman RI; Chu EY; Kim CC; Kirkwood JM; Grossman D
    Cancer Med; 2023 Dec; 12(24):22103-22108. PubMed ID: 38098216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular diagnostics in melanoma].
    Lang R; Bauer JW; Laimer M
    Hautarzt; 2015 Apr; 66(4):277-81. PubMed ID: 25783213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular classification and markers of malignant melanoma].
    Tímár J; Hársing J; Somlai B
    Magy Onkol; 2013 Jun; 57(2):73-8. PubMed ID: 23795351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.
    Nguyen BT; Kim RS; Bretana ME; Kegley E; Schefler AC
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):421-427. PubMed ID: 29185101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New techniques in dermatopathology that help to diagnose and prognosticate melanoma.
    Carlson JA; Ross JS; Slominski AJ
    Clin Dermatol; 2009; 27(1):75-102. PubMed ID: 19095155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Paradigmatic shift in oncology: individualized melanoma treatment].
    Hansson J; Djureen-Mårtenson E; Edvinsson F; Falkenius J; Friesland S; Masucci G; Månsson-Brahme E; Ragnarsson-Olding B; Sjödin H; Wolodarski M; Frohm-Nilsson M; Lapins J
    Lakartidningen; 2011 May 18-24; 108(20):1092-3. PubMed ID: 21815339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.